Atorvastatin Calcium
Product Images NDC 68258-6044

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68258-6044). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 68258-6041-xx (Ndc 68258 6041 Xx Ohm)

Atorvastatin Calcium 10 mg film-coated tablet label from Dispensing Solutions, Inc. The label includes dosage instructions, NDC 68258-6041-XX, product number 6041-X, and states each tablet contains atorvastatin calcium equivalent to 10 mg atorvastatin. It also features storage warnings and manufacturer information from OHM Laboratories Inc.*

FDA Label Image

Ndc 68258-6042-xx (Ndc 68258 6042 Xx Ohm)

Label for Atorvastatin Calcium 20 mg tablets by Dispensing Solutions, Inc. It shows the NDC 68258-6042-XX and product number 6042-X. The label is white with black text, includes a barcode and a QR code, dosage instructions to take tablets orally once daily, and storage instructions to keep out of children's reach and store at 68°-77°F. Manufacturer noted as OHM Laboratories Inc., North Brunswick, NJ.*

FDA Label Image

Ndc 68258-6043-xx (Ndc 68258 6043 Xx Ohm)

Atorvastatin Calcium 40 mg tablets packaging label from Dispensing Solutions, Inc. The label shows the product name, strength, dosage form (tablets), and NDC 68258-6043. It includes manufacturer information (OHM Laboratories Inc.) and storage instructions. The label also has sample lot and Rx number details, along with usage instructions and warnings.*

FDA Label Image

Ndc 68258-6044-xx (Ndc 68258 6044 Xx Ohm)

Atorvastatin Calcium 80 mg tablet label showing the product name, strength, dosage form as film-coated tablets, and NDC 68258-6044-XX. The label indicates a prescription-only product distributed by Dispensing Solutions, Inc., with manufacturer information from Ohm Laboratories Inc. Additional text includes dosing instructions, storage conditions, warnings, and lot and expiration placeholders.*

FDA Label Image

Figure1 (Figatorva1)

A cumulative incidence line graph comparing Atorvastatin and placebo groups over 3.5 years. The vertical axis represents cumulative incidence percentage, and the horizontal axis shows time in years. The Atorvastatin group curve rises more slowly than the placebo, indicating lower cumulative incidence over time.*

FDA Label Image

Figure2 (Figatorva2)

A line graph showing cumulative hazard percentage over time in years for Atorvastatin and placebo groups up to four years of follow-up. The graph compares time to first primary endpoint, with Atorvastatin having a consistently lower cumulative hazard than placebo, including a hazard ratio (HR) of 0.63 with confidence interval and a p-value indicated.*

FDA Label Image

Figure3 (Figatorva3)

A line chart comparing the percentage of subjects experiencing a major cardiovascular event over time between two atorvastatin dosage groups: 10 mg and 80 mg. The x-axis shows time to first major cardiovascular endpoint in years (0 to 5), and the y-axis shows the percentage of subjects experiencing the event (0 to 0.2). Two lines represent the incidences for Atorvastatin 10 mg and Atorvastatin 80 mg groups, with a hazard ratio of 0.78 indicated.*

FDA Label Image

Structure (Structureatorva)

Chemical structure of Atorvastatin Calcium showing the molecular arrangement including phenyl groups, hydroxyl groups, and the calcium ion complexed with water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.